Illinois may cut compounded GLP-1s from workers' comp coverage

Illinois lawmakers are considering a bill that would change what compounded drugs workers' compensation insurance can pay for. If it passes, injured workers who currently rely on compounded semaglutide as part of their treatment could lose access to that option through their comp coverage. This matters most to workers whose recovery plans include a compounded GLP-1 medication, since a shift in coverage rules could force a change in how they pay for it, or whether they can continue it at all.

The bill, identified as HB 1256, would restrict what compounded drugs Illinois workers' compensation insurance is allowed to cover. Compounded medications are prepared by a pharmacy rather than manufactured by a drug company in fixed doses, and they are sometimes used when a patient needs a different strength or form of a drug than what is commercially available. For injured workers, compounded semaglutide has been one such option, covered under a state's workers' comp system as part of an approved treatment plan. If this bill becomes law, that coverage could be narrowed or removed, which would leave affected workers to either find another way to pay for the medication or stop using it. The bill has not yet passed, so the outcome and its effective scope are still undetermined.

If you are an injured worker in Illinois currently receiving compounded semaglutide through your workers' compensation coverage, it may help to keep track of this bill's progress and talk with your claims administrator about what would happen to your coverage if it passes. You may also want to ask your prescribing provider whether a non-compounded alternative would be appropriate for your situation, in case your compounded option becomes unavailable. Staying informed now gives you more time to plan, rather than reacting after a change in coverage has already taken effect.

By Amanda Bonello